| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
March 15, 2018
BALLINA, Co. Tipperary (Ireland) and BREA, Calif. (USA) – (March 15, 2018) — Long-term agreement expands Beckman Coulter customers’ access to high-quality QC products, supporting efficient...
-
February 20, 2018
Fully contained automation solution boosts laboratory productivity, workflow flexibility and testing quality BREA, Calif. — (Feb. 20 2018) — Beckman Coulter Diagnostics and NTE-SENER, the...
-
January 4, 2018
Beckman Coulter Diagnostics today announced the addition of 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) assays to its broad menu of drugs-of-abuse tests that meet the demands of onsite testing...
-
December 21, 2017
Beckman Coulter Diagnostics announced FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic (IVD) use in the U.S. This simple test aids healthcare providers in the...
-
November 27, 2017
Beckman Coulter is committed to ensuring customers receive the highest quality assays, on-time, to help healthcare and laboratory professionals provide better patient care. To further these goals,...
